Company Farmasept Srl with Fiscal Code 22228590
recorded a turnover of 2024 of
775.101,
with a net profit of
14.976
and having an average number of employees of
13.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Farmasept Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
226.896
228.262
0
236.049
259.771
277.266
302.059
328.676
464.745
775.101
Total Income - EUR
228.817
228.734
0
244.605
259.773
277.268
302.061
328.730
464.979
775.106
Total Expenses - EUR
204.500
223.400
0
235.496
254.284
256.837
286.548
309.553
456.045
743.055
Gross Profit/Loss - EUR
24.317
5.334
0
9.109
5.489
20.432
15.512
19.177
8.934
32.051
Net Profit/Loss - EUR
20.410
5.334
0
6.663
2.891
17.858
12.824
16.273
4.883
14.976
Employees
7
7
0
7
7
7
7
7
10
13
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 67.7%, from 464.745 euro in the year 2023, to 775.101 euro in 2024.
The Net Profit increased by 10.120 euro, from 4.883 euro in 2023, to 14.976 in the last year.
Check the financial reports for the company - Farmasept Srl
Financial Rating - FARMASEPT SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Farmasept Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Farmasept Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Farmasept Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
138.335 euro in 2024 which includes Inventories of
37.316 euro, Receivables of
90.998 euro and cash availability of
10.022 euro.
The company's Equity was valued at
141.872 euro, while total Liabilities amounted to
65.401 euro.
Equity increased by 14.976 euro, from 127.609 euro in 2023, to 141.872 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Farmasept Srl